Not Yet RecruitingNot Applicable

Intensive Music Therapy on Cognitive Function in Subacute Stroke Rehabilitation in Malaysia

36 participantsStarted 2026-05-01

Plain-language summary

The purpose of this study is to explore whether intensive music therapy can help improve cognitive functions like memory, attention, and decision-making skills in stroke patients who are undergoing rehabilitation. This is a feasibility study, meaning it's also designed to see how practical it is to include music therapy as part of stroke rehabilitation. The investigators want to learn how well patients can participate in and stick with this type of therapy, and whether it fits well with other treatments that stroke patients usually receive. By understanding this, the investigators can assess the resources, staff training, and planning needed for music therapy to be part of stroke recovery in the future. The study will also help the investigators estimate the effects of music therapy, which will be used to design a larger, more detailed study in the future.

Who can participate

Age range

18 Years – 75 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed with ischemic or haemorrhagic stroke confirmed by CT scan * Duration of stroke within the first 3 months * Aged 18 - 75 years old * Ability to provide informed consent * Understands Bahasa Melayu or English with basic communication abilities to follow instructions during therapy sessions * Mild to moderate cognitive impairments with MoCA score of 10-25. Exclusion Criteria: * Severe aphasia * Significant uncorrected hearing or visual impairments preventing engagement in music therapy. * Severe or unstable medical conditions (e.g., uncontrolled hypertension or diabetes). * Medications that significantly impair cognition or motor function (e.g., high dose sedatives). * History of neurological diseases other than stroke (eg, Parkinson's disease).

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Montreal Cognitive Assessment (MoCA)

Timeframe: This will be assessed at baseline, after completion of 8 sessions, an average of 2 weeks and also at 1 month after completion.

Trail Making Test (TMT)

Timeframe: This will be assessed at baseline, after completion of 8 sessions, an average of 2 weeks and also at 1 month after completion.

Digit Span (Forward and Backward)

Timeframe: This will be assessed at baseline, after completion of 8 sessions, an average of 2 weeks and also at 1 month after completion.

Clock Drawing Test (CDT)

Timeframe: This will be assessed at baseline, after completion of 8 sessions, an average of 2 weeks and also at 1 month after completion.

Trial details

NCT IDNCT06763003

SponsorUniversity of Malaya

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-31

Contact for this trial

MAZLINA BINTI MAZLAN PROF, MBBS

+60379675181 mazlinamazlan@um.edu.my

View on ClinicalTrials.gov More Rehabilitation trials

Plain-language summary

Who can participate

Age range

18 Years – 75 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Montreal Cognitive Assessment (MoCA)

Timeframe: This will be assessed at baseline, after completion of 8 sessions, an average of 2 weeks and also at 1 month after completion.

Trail Making Test (TMT)

Timeframe: This will be assessed at baseline, after completion of 8 sessions, an average of 2 weeks and also at 1 month after completion.

Digit Span (Forward and Backward)

Timeframe: This will be assessed at baseline, after completion of 8 sessions, an average of 2 weeks and also at 1 month after completion.

Clock Drawing Test (CDT)

Timeframe: This will be assessed at baseline, after completion of 8 sessions, an average of 2 weeks and also at 1 month after completion.